Kosmos Trio and Ejection Fraction Pivotal Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Michigan
-
Dearborn, Michigan, United States, 48126
- Revival Research Institute LLC
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Aged 18-89 years of age
- Have capacity to provide written consent either themselves or via healthcare proxy as determined by subjects' clinical care teams
- Have an anticipated timeline in the EDOU long enough to allow for completion of study procedures without causing delay to subjects' usual clinical care
Exclusion Criteria:
- Heart rate > 110 beats per minute at the time of recruitment
- Pregnant women
- Prior chest surgery
- Chest wall deformities or injuries (i.e. wounds, infections, etc)
- Limited mobility precluding them from turning in bed independently
- Speak a primary language other than English or Spanish
- Vulnerable populations including: patients being evaluated for psychiatric crises, incarcerated individuals
- Unwilling or unable to consent to study procedures
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Study Subjects
Ultrasound scans conducted by novice users and experts on this cohort.
|
EchoNous KOSMOS
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of Global Left Ventricular Function
Time Frame: Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
A panel of cardiologists will access and determine via a majority vote if a study exam acquired by a nurses is of sufficient image quality to make a qualitative visual assessment of the Global Left Ventricular Function.
|
Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
|
Assessment of Left Ventricular Size
Time Frame: Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
A panel of cardiologists will access and determine via a majority vote if a study exam acquired by a nurse is of sufficient image quality to make a qualitative visual assessment of the Left Ventricular Size.
|
Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
|
Assessment of Non-Trivial Pericardial Effusion
Time Frame: Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
A panel of cardiologists will access and determine via a majority vote if a study exam acquired by a nurse is of sufficient image quality to make a qualitative visual assessment of Non-Trivial Pericardial Effusion.
|
Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
|
Assessment of Right Ventricular Size
Time Frame: Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
A panel of cardiologists will access and determine via a majority vote if a study exam acquired by a nurse is of sufficient image quality to make a qualitative visual assessment of Right Ventricle Size.
|
Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of Automatic Structure Labelling
Time Frame: Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
A panel of cardiologists will access and determine via a majority vote if the frame-level false discovery rate (FDR) of automated cardiac structure labeling as determined by expert cardiologists for scans acquired by cardiac sonographers.
|
Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
|
Manual vs. KOSMOS-EF for Sonographer Scans
Time Frame: Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
Measurements are computed for A4C and A2C scans acquired by sonographers .
We will compare KOSMOS-EF LVEF calculation to LVEF calculated by a panel of cardiologists via a majority vote.
|
Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
|
Assessment of Left Atrial Size
Time Frame: Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
A panel of cardiologists will access and determine via a majority vote if a study exam acquired by a nurse is of sufficient image quality to make a qualitative visual assessment of Left Atrial Size.
|
Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ECHO-004
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.